Eble JN, Sauter G., Epstein JI, Sesterhenn IA - iarc

1752. Mizutani S, Okuda N, Sonoda T
(1973). Granular cell myoblastoma of the
bladder: report of an additional case. J
Urol 110: 403-405.
1753. Moch H, Gasser T, Amin MB,
Torhorst J, Sauter G, Mihatsch MJ (2000).
Prognostic utility of the recently recommended
histologic classification and
revised TNM staging system of renal cell
carcinoma: a Swiss experience with 588
tumors. Cancer 89: 604-614.
1754. Moch H, Presti JCJr, Sauter G,
Buchholz N, Jordan P, Mihatsch MJ,
Waldman FM (1996). Genetic aberrations
detected by comparative genomic
hybridization are associated with clinical
outcome in renal cell carcinoma. Cancer
Res 56: 27-30.
1755. Moch H, Sauter G, Buchholz N,
Gasser TC, Bubendorf L, Waldman FM,
Mihatsch MJ (1997). Epidermal growth
factor receptor expression is associated
with rapid tumor cell proliferation in renal
cell carcinoma. Hum Pathol 28: 1255-1259.
1756. Moch H, Sauter G, Gasser TC,
Bubendorf L, Richter J, Presti JCJr,
Waldman FM, Mihatsch MJ (1998). EGF-r
gene copy number changes in renal cell
carcinoma detected by fluorescence in
situ hybridization. J Pathol 184: 424-429.
1757. Moch H, Sauter G, Mihatsch MJ,
Gudat F, Epper R, Waldman FM (1994). p53
but not erbB-2 expression is associated
with rapid tumor proliferation in urinary
bladder cancer. Hum Pathol 25: 1346-1351.
1758. Moch H, Sauter G, Moore D,
Mihatsch MJ, Gudat F, Waldman F (1993).
p53 and erbB-2 protein overexpression
are associated with early invasion and
metastasis in bladder cancer. Virchows
Arch A Pathol Anat Histopathol 423: 329-
334.
1759. Moch H, Schraml P, Bubendorf L,
Mirlacher M, Kononen J, Gasser T,
Mihatsch MJ, Kallioniemi OP, Sauter G
(1999). High-throughput tissue microarray
analysis to evaluate genes uncovered by
cDNA microarray screening in renal cell
carcinoma. Am J Pathol 154: 981-986.
1760. Moch H, Schraml P, Bubendorf L,
Richter J, Gasser TC, Mihatsch MJ, Sauter
G (1998). Intratumoral heterogeneity of von
Hippel-Lindau gene deletions in renal cell
carcinoma detected by fluorescence in
situ hybridization. Cancer Res 58: 2304-
2309.
1761. Moertel CL, Watterson J, McCormick
SR, Simonton SC (1995). Follicular large
cell lymphoma of the testis in a child.
Cancer 75: 1182-1186.
1762. Mohammed AY, Matthew L, Harmse
JL, Lang S, Townell NH (1999). Multiple
leiomyoma of the renal capsule. Scand J
Urol Nephrol 33: 138-139.
1763. Molenaar WM, Oosterhuis JW,
Meiring A, Sleyfer DT, Schraffordt Koops
H, Cornelisse CJ (1986). Histology and
DNA contents of a secondary malignancy
arising in a mature residual lesion six
years after chemotherapy for a disseminated
nonseminomatous testicular tumor.
Cancer 58: 264-268.
1764. Molinie V, Liguory Brunaud MD,
Chiche R (1992). [Primary carcinoid tumor
of the kidney. Apropos of a case with
immunohistochemical study]. Arch Anat
Cytol Pathol 40: 289-293.
1765. Moll R, Franke WW, Schiller DL,
Geiger B, Krepler R (1982). The catalog of
human cytokeratins: patterns of expression
in normal epithelia, tumors and cultured
cells. Cell 31: 11-24.
1766. Moller H (1993). Clues to the aetiology
of testicular germ cell tumours from
descriptive epidemiology. Eur Urol 23: 8-
13.
1767. Moller H, Evans H (2003).
Epidemiology of gonadal germ cell cancer
in males and females. APMIS 111: 43-46.
1768. Moller H, Prener A, Skakkebaek NE
(1996). Testicular cancer, cryptorchidism,
inguinal hernia, testicular atrophy, and
genital malformations: case-control studies
in Denmark. Cancer Causes Control 7:
264-274.
1769. Moller H, Skakkebaek NE (1997).
Testicular cancer and cryptorchidism in
relation to prenatal factors: case-control
studies in Denmark. Cancer Causes
Control 8: 904-912.
1770. Moller H, Skakkebaek NE (1999). Risk
of testicular cancer in subfertile men:
case-control study. BMJ 318: 559-562.
1771. Moncure CW, Prout GRJr (1970).
Antigenicity of human prostatic acid phosphatase.
Cancer 25: 463-467.
1772. Montie JE, Wood DPJr, Pontes JE,
Boyett JM, Levin HS (1989).
Adenocarcinoma of the prostate in cystoprostatectomy
specimens removed for
bladder cancer. Cancer 63: 381-385.
1773. Montironi R (2001). Prognostic factors
in prostate cancer. BMJ 322: 378-379.
1774. Montironi R (2001). Spectrum of prostatic
non-epithelial tumour-like conditions
and tumours. Pathol Res Pract 197:
653-655.
1775. Montironi R, Mazzucchelli R, Algaba
F, Bostwick DG, Krongrad A (2000).
Prostate-specific antigen as a marker of
prostate disease. Virchows Arch 436: 297-
304.
1776. Montironi R, Mazzucchelli R,
Scarpelli M (2002). Precancerous lesions
and conditions of the prostate: from morphological
and biological characterization
to chemoprevention. Ann N Y Acad Sci
963: 169-184.
1777. Montironi R, Thompson D, Bartels PH
(1999). Premalignant lesions of the
prostate. In: Recent Advances in
Histopathology, DG Lowe, JCE
Underwood, eds. Churchill Livingstone:
Edinburgh, pp. 147-172.
1778. Mor Y, Leibovich I, Raviv G, Nass D,
Medalia O, Goldwasser B, Nativ O (1995).
Testicular seminoma: clinical significance
of nuclear deoxyribonucleic acid ploidy
pattern as studied by flow cytometry. J
Urol 154: 1041-1043.
1779. Moran CA, Kaneko M (1990).
Malignant fibrous histiocytoma of the
glans penis. Am J Dermatopathol 12: 182-
187.
1780. Moreno JG, Croce CM, Fischer R,
Monne M, Vihko P, Mulholland SG,
Gomella LG (1992). Detection of hematogenous
micrometastasis in patients with
prostate cancer. Cancer Res 52: 6110-
6112.
1781. Morgan DR, Brame KG (1999).
Granulosa cell tumour of the testis displaying
immunoreactivity for inhibin. BJU
Int 83: 731-732.
1782. Morgan DR, Dixon MF, Harnden P
(1998). Villous adenoma of urethra associated
with tubulovillous adenoma and adenocarcinoma
of rectum. Histopathology
32: 87-89.
1783. Morgan E, Kidd JM (1978). Undifferentiated
sarcoma of the kidney: a tumor of
childhood with histopathologic and clinical
characteristics distinct from Wilms’
tumor. Cancer 42: 1916-1921.
1784. Morganti G, Gianferrari L, Cresseri A,
Arrigoni G, Lovati G (1956). Recherches
clinico-statistiques et génétiques sur les
néoplasies de la prostate. Acta Genet Med
Gemellol (Roma) 6: 304-305.
1785. Morin G, Houlgatte A, Camparo P,
Sarrazin JL, Berlizot P, Houdelette P (1998).
[Solitary fibrous tumor of the seminal vesicles:
apropos of a case]. Prog Urol 8: 92-94.
1786. Morita R, Ishikawa J, Tsutsumi M,
Hikiji K, Tsukada Y, Kamidono S, Maeda S,
Nakamura Y (1991). Allelotype of renal cell
carcinoma. Cancer Res 51: 820-823.
1787. Moriyama M, Akiyama T, Yamamoto
T, Kawamoto T, Kato T, Sato K, Watanuki T,
Hikage T, Katsuta N, Mori S (1991).
Expression of c-erbB-2 gene product in
urinary bladder cancer. J Urol 145: 423-
427.
1788. Morrison KB, Tognon CE, Garnett
MJ, Deal C, Sorensen PH (2002). ETV6-
NTRK3 transformation requires insulin-like
growth factor 1 receptor signaling and is
associated with constitutive IRS-1 tyrosine
phosphorylation. Oncogene 21: 5684-5695.
1789. Morrissey C, Martinez A, Zatyka M,
Agathanggelou A, Honorio S, Astuti D,
Morgan NV, Moch H, Richards FM, Kishida
T, Yao M, Schraml P, Latif F, Maher ER
(2001). Epigenetic inactivation of the
RASSF1A 3p21.3 tumor suppressor gene in
both clear cell and papillary renal cell carcinoma.
Cancer Res 61: 7277-7281.
1790. Moss AH, Peterson LJ, Scott CW,
Winter K, Olin DB, Garber RL (1982).
Delayed diagnosis of juxtaglomerular cell
tumor hypertension. N C Med J 43: 705-707.
1791. Mostafa MH, Helmi S, Badawi AF,
Tricker AR, Spiegelhalder B, Preussmann
R (1994). Nitrate, nitrite and volatile N-
nitroso compounds in the urine of
Schistosoma haematobium and
Schistosoma mansoni infected patients.
Carcinogenesis 15: 619-625.
1792. Mostert M, Rosenberg C, Stoop H,
Schuyer M, Timmer A, Oosterhuis W,
Looijenga LH (2000). Comparative genomic
and in situ hybridization of germ cell
tumors of the infantile testis. Lab Invest 80:
1055-1064.
1793. Mostert MC, Verkerk AJ, van de Pol
M, Heighway J, Marynen P, Rosenberg C,
van Kessel AG, van Echten J, de Jong B,
Oosterhuis JW, Looijenga LH (1998).
Identification of the critical region of 12p
over-representation in testicular germ cell
tumors of adolescents and adults.
Oncogene 16: 2617-2627.
1794. Mostert MM, van de Pol M, Olde
Weghuis D, Suijkerbuijk RF, Geurts van
Kessel A, van Echten J, Oosterhuis JW,
Looijenga LH (1996). Comparative genomic
hybridization of germ cell tumors of the
adult testis: confirmation of karyotypic
findings and identification of a 12p-amplicon.
Cancer Genet Cytogenet 89: 146-152.
1795. Mostert MM, van de Pol M, van
Echten J, Olde Weghuis D, Geurts van
Kessel A, Oosterhuis JW, Looijenga LH
(1996). Fluorescence in situ hybridizationbased
approaches for detection of 12p
overrepresentation, in particular i(12p), in
cell lines of human testicular germ cell
tumors of adults. Cancer Genet Cytogenet
87: 95-102.
1796. Mostofi FK (1980). Pathology of germ
cell tumors of testis: a progress report.
Cancer 45: 1735-1754.
1797. Mostofi FK (1985). Histological
change ostensibly induced by therapy in
the metastasis of germ cell tumors of
testis. Prog Clin Biol Res 203: 47-60.
1798. Mostofi FK, Davis CJ, Sesterhenn IA
(1999). World Health Organization
International Histological Classification of
Tumours. Histological Typing of Urinary
Bladder Tumours. 2 nd Edition. Springer
Verlag: Berlin Heidelberg.
1799. Mostofi FK, Davis CJJr, Sesterhenn
IA (1992). Carcinoma of the male and
female urethra. Urol Clin North Am 19: 347-
358.
1800. Mostofi FK, Price EB (1973). Tumors
of the Male Genital System. 2 nd Edition.
AFIP: Washington, DC.
1801. Mostofi FK, Sesterhenn I, Sobin LH
(1980). International Histological
Classification of Tumours. Histological
Typing of Prostate Tumours. WHO:
Geneva.
1802. Mostofi FK, Sesterhenn IA (1984).
Pathology of epithelial tumors and carcinoma
in situ of bladder. Prog Clin Biol Res
162A: 55-74.
1803. Mostofi FK, Sesterhenn IA (1985).
Pathology of germ cell tumors of testes.
Prog Clin Biol Res 203: 1-34.
1804. Mostofi FK, Sesterhenn IA (1986).
The diagnosis of choriocarcinoma in the
male. In: Germ Cell Tumours II, WG Jones,
A Milford-Ward, CK Anderson, eds.
Pergamon Press: Oxford.
1805. Mostofi FK, Sesterhenn IA (1998).
World Health Organization International
Histological Classification of Tumours.
Histological Typing of Testis Tumours. 2 nd
Edition. Springer-Verlag: Berlin
Heidelberg.
1806. Mostofi FK, Sesterhenn IA, Davis CJ,
Mesonero C (2002). Testicular teratoma in
adults. Int J Cancer Suppl 13: 752.
1807. Mostofi FK, Sesterhenn IA, Davis
CJJr (1987). Immunopathology of germ cell
tumors of the testis. Semin Diagn Pathol 4:
320-341.
1808. Mostofi FK, Sesterhenn IA, Davis
CJJr (1988). Developments in histopathology
of testicular germ cell tumors. Semin
Urol 6: 171-188.
1809. Mostofi FK, Sobin LH (1977). World
Health Organization International
Histological Classification of Tumours.
Histological Typing of Testicular Tumours.
WHO: Geneva.
1810. Mostofi FK, Sobin LH, Torloni H
(1973). World Health Organization
International Histological Classification of
Tumours. Histological Typing of Urinary
Bladder Tumours. 1st Edition. WHO:
Geneva.
1811. Mostofi FK, Theiss EA, Ashley DJB
(1959). Tumors of specialized gonadal stroma
in human male patients. Cancer 12:
944-957.
1812. Mostofi FK, Theiss EA, Ashley DJB
(1959). Tumors of the specialized gonadal
stroma in human male patients: androblastoma,
Sertoli cell tumor, granulosa Theca
cell tumor of the testis, and gonadal stromal
tumor. Cancer 12: 944-957.
1813. Mostofi FK, Thomson RV, Dean AL
(1955). Mucinous adenocarcinoma of the
urinary bladder. Cancer 8: 741-758.
1814. Mott LJ (1979). Squamous cell carcinoma
of the prostate: report of 2 cases and
review of the literature. J Urol 121: 833-
835.
1815. Motzer RJ, Amsterdam A, Prieto V,
Sheinfeld J, Murty VV, Mazumdar M, Bosl
GJ, Chaganti RS, Reuter VE (1998).
Teratoma with malignant transformation:
diverse malignant histologies arising in
men with germ cell tumors. J Urol 159: 133-
138.
References 333